These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Robotic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma. Ten Haaft BHEA, Franssen S, van Dorst RWJJ, Rousian M, Pilz da Cunha G, de Wilde RF, Erdmann JI, Groot Koerkamp B, Hagendoorn J, Swijnenburg RJ. Ann Surg Oncol; 2024 Jun; 31(6):4022-4029. PubMed ID: 38498089 [Abstract] [Full Text] [Related]
3. [A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy]. Nishizawa T, Higuchi H, Takaishi H, Iizuka H, Izumiya M, Yamagishi Y, Hisamatsu T, Suzuki H, Masaoka T, Iwasaki E, Nagata H, Hibi T. Gan To Kagaku Ryoho; 2006 Nov; 33(11):1657-9. PubMed ID: 17108736 [Abstract] [Full Text] [Related]
9. The SwiftNINJA steerable microcatheter for continuous hepatic artery infusion chemotherapy for the treatment of advanced intrahepatic cholangiocarcinoma. Zhang D, Zheng L, Rao Q, Zhao Z. Asian J Surg; 2022 Jan; 45(1):656-658. PubMed ID: 34810117 [No Abstract] [Full Text] [Related]
10. Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma--initial experience. Tanaka N, Yamakado K, Nakatsuka A, Fujii A, Matsumura K, Takeda K. Eur J Radiol; 2002 Jan; 41(1):42-8. PubMed ID: 11750151 [Abstract] [Full Text] [Related]
11. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study. Muaddi H, D'Angelica M, Wiseman JT, Dillhoff M, Latchana N, Roke R, Ko YJ, Carpizo D, Spencer K, Fields RC, Williams G, Aucejo F, Acevedo-Moreno LA, Billingsley KG, Walker BS, Mayo SC, Karanicolas PJ. J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919 [Abstract] [Full Text] [Related]
15. Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. Cercek A, D'Angelica M, Power D, Capanu M, Gewirtz A, Patel D, Allen P, Fong Y, DeMatteo RP, Jarnagin WR, Kemeny NE. Ann Surg Oncol; 2014 Feb; 21(2):479-86. PubMed ID: 24154839 [Abstract] [Full Text] [Related]